Effect of chronic Pseudomonas aeruginosa infection on the development of atherosclerosis in a rat model

Clinical Microbiology and Infection

Volumn 10, Issue 8, 2004, Pages 705-708

  Turkay, C ^a   Saba, R ^a   Pahin, N ^a   Altunbap, H ^a   Ozbudak O ^a   Akkaya, B ^a   Ozbilim G ^a   Golbapy Y ^a   Turkay, M ^a   Oounc D ^a   Bayezid, O ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Chronic infection; Pathogenesis; Pseudomonas aeruginosa; Rat model

Indexed keywords

CHOLESTEROL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTERY DIAMETER; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL DIET; CHRONIC LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY; DISEASE MODEL; GRAM NEGATIVE INFECTION; HEART; IMAGE ANALYSIS; INOCULATION; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RAT; RAT STRAIN;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RATTUS NORVEGICUS;

EID: 4544317038     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00920.x     Document Type: Article

References (19)

1. US Department of Health and Human Services. National Heart, Lung and Blood Institute fact book: Fiscal Year 1995. Bethesda, MD: US Department of Health and Human Services, 1996.
2. Muhlestein JB. Coronary infection and coronary artery disease. Med Clin North Am 2000; 84: 123-147.
3. Zhu J, Quyyumi AA, Norman JE et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000; 85: 140-146.
4. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436.
5. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: 20-28.
6. Leinonen M, Saikku P. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002; 2: 11-17.
7. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation 1997; 96: 4095-4103.
8. Anderson JL, Muhlestein JB, Carlquist JF et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 1999; 99: 1540-1547.
9. Muhlestein JB, Anderson JL, Hammond EH et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633-636.
10. Hisich E, Zhou YF, Paigen B, Johnson TM, Burnett MS, Epstein SE. Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice. Atherosclerosis 2001; 156: 23-28.
11. Alber DG, Powell KL, Vallance P, Goodwin DA, Grahame-Clarke C. Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation 2000; 102: 779-785.
12. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 1999; 103: 747-753.
13. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases, 5th edn. New York, NY: Churchill Livingstone, 2000; 2310-2335.
14. Cash HA, Woods DE, McCullough B, Johanson WG, Bass JA. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am Rev Respir Dis 1979; 119: 453-459.
15. Johansen HK, Espersen F, Pedersen SS, Hougen HP, Rygaard K, Hoiby N. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats. APMIS 1993; 101: 207-225.
16. Yu H, Hanes M, Chrisp CP, Boucher JC, Deretic V. Microbial pathogenesis in cystic fibrosis. Pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. Infect Immun 1998; 66: 280-288.
17. Fraunberger P, Guenther P, Cremer P, Werdan K, Walli AK. Association of serum tumor necrosis factor levels with decrease of cholesterol during septic schock. Shock 1998; 10: 359-363.
18. Sammalkorpi KT, Valtonen VV, Kertulla Y, Nikkila E, Taskinen NR. Changes in serum lipoprotein pattern induced by acute infections. Metabolism 1988; 37: 859-865.
19. Fiser RH, Enniston JC, Beisel WR. Infection with Diplococcus pneumonia and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J Infect Dis 1972; 125: 54-60.